Company Contents
Quick Facts & Snapshot
Summary
The Bio Preservation market is entering a robust expansion phase as biobanks, cell therapy developers, and diagnostic labs scale globally. Safety, regulatory compliance, and cold-chain reliability are driving premium demand, allowing leading Bio Preservation market companies to consolidate share. With the market rising from US$ 1.63 Billion in 2025 to US$ 2.93 Billion by 2032, an 8.70% CAGR will reward innovation-led players.
Source: Secondary Information and ReportMines Research Team - 2026
Ranking Methodology
Rankings of Bio Preservation market companies are based on a composite score combining quantitative and qualitative indicators. Core metrics include 2025 Bio Preservation revenue, multi-year revenue trajectory, and share of high-growth segments such as cell therapy and biobanking. We also assess contract wins with leading pharma, CROs, and hospital networks, installed base of freezers and cryogenic systems, and breadth of consumables and media portfolios. Technology differentiation, IP strength, and integration of digital monitoring, automation, and quality-control features are weighted alongside after-sales service coverage and global cold-chain support. Each company receives a normalized score across revenue scale, growth, innovation, geographic reach, and customer stickiness. The final ranking reflects balanced performance rather than size alone, highlighting Bio Preservation market companies that combine commercial strength with sustainable competitive advantages.
Top 10 Companies in Bio Preservation
Source: Secondary Information and ReportMines Research Team - 2026
Detailed Company Profiles
Thermo Fisher Scientific Inc.
Global life-science tools leader providing end-to-end bio-preservation equipment, consumables, and monitoring platforms for research, clinical, and biopharma customers.
Merck KGaA (MilliporeSigma)
Science and technology company offering high-value preservation media and reagents supporting bioprocessing, cell therapy, and genomic applications.
Becton, Dickinson and Company (BD)
Diversified medical technology company with strong presence in sample collection, stabilization, and transport products for diagnostics and research.
BioLife Solutions, Inc.
Specialist biotechnology company providing preservation media and storage systems tailored to cell and gene therapy developers.
Chart Industries, Inc. (MVE Biological Solutions)
Industrial engineering company delivering cryogenic storage equipment and systems for large-scale biological sample preservation.
Haier Biomedical Co., Ltd.
China-based manufacturer offering broad ranges of biomedical freezers and refrigerators targeted at hospitals and public health agencies.
PHC Holdings Corporation (PHCbi)
Japanese provider of high-performance laboratory equipment emphasizing reliability and energy efficiency for research environments.
Helmer Scientific Inc.
Privately held company specializing in medical-grade refrigeration for blood management and clinical product preservation.
Cryoport, Inc.
Logistics and technology company focused on temperature-controlled supply chain solutions for advanced therapies and clinical trials.
Brooks Automation (Brooks Life Sciences / Azenta, Inc.)
Automation-centric company delivering robotic sample storage and informatics for advanced biobanking and pharma discovery.
SWOT Leaders
Thermo Fisher Scientific Inc.
SWOT Snapshot
Extensive global installed base, broad product portfolio across hardware and consumables, strong brand and service networks.
Complex portfolio structure, premium pricing versus regional competitors, integration challenges after acquisitions.
Growth in cell and gene therapies, expansion of large national biobanking projects, increased demand for connected monitoring.
Price pressure from Asian manufacturers, regulatory shifts on energy efficiency, and supply-chain volatility for critical components.
Merck KGaA (MilliporeSigma)
SWOT Snapshot
Deep biochemical expertise, strong IP in preservation media, close relationships with bioprocessing and CGT customers.
Limited ownership of core hardware platforms, dependency on third-party equipment ecosystems, complex global regulatory footprint.
Bundling reagents with single-use systems, supporting continuous bioprocessing, and expanding customized media offerings.
Intensifying competition from specialized media firms, potential raw-material constraints, and pricing scrutiny in mature markets.
Becton, Dickinson and Company (BD)
SWOT Snapshot
Unmatched reach in hospitals and labs, trusted sample-collection brand, strong regulatory and quality track record.
Lower exposure to premium CGT and automated biobanking segments, slower innovation cadence in niche advanced areas.
Leveraging installed base to cross-sell advanced preservation solutions, rising test volumes, and centralization of lab networks.
Commoditization of basic consumables, hospital procurement consolidation, and competition from agile specialty suppliers.
Bio Preservation Market Regional Competitive Landscape
North America remains the largest Bio Preservation market, driven by dense networks of biobanks, academic centers, and cell therapy developers. Thermo Fisher Scientific Inc., BioLife Solutions, and Cryoport, Inc. are particularly strong, leveraging proximity to major CGT clusters. Funding for precision medicine and oncology trials sustains premium demand for advanced solutions.
Europe shows balanced growth, underpinned by national biobank programs, stringent data and quality regulations, and strong public healthcare. Merck KGaA (MilliporeSigma), PHC Holdings Corporation, and Brooks Automation secure share through compliance-centric offerings. EU sustainability and energy-efficiency policies encourage replacement of legacy freezers with newer, low-consumption systems from leading Bio Preservation market companies.
Asia Pacific is the fastest-growing region, propelled by China’s and India’s expanding clinical-trial infrastructure and rising investments in genomic medicine. Haier Biomedical Co., Ltd. and Thermo Fisher Scientific Inc. compete closely, with Haier benefiting from local manufacturing. Demand for mid-priced, IoT-enabled freezers and cryogenic systems is surging among hospitals, CROs, and regional biobanks.
Latin America witnesses gradual but steady adoption, anchored by reference laboratories, public blood banks, and international research collaborations. Chart Industries, Inc. and Helmer Scientific Inc. participate mainly in Tier-1 projects, often via distributors. Budget constraints favor cost-effective offerings, yet high-end equipment from established Bio Preservation market companies remains essential for flagship centers.
The Middle East and Africa present a fragmented yet rising opportunity, driven by new tertiary hospitals, vaccination programs, and donor-funded disease-surveillance labs. Haier Biomedical Co., Ltd. and BD compete with regional suppliers on price and reliability. High ambient temperatures amplify demand for robust, validated preservation systems and long-term service contracts.
In advanced economies across all regions, automation-led biobanking and population genomics initiatives accelerate adoption of robotics and software-centric solutions. Brooks Automation and Thermo Fisher Scientific Inc. are visible in these projects, integrating automated storage with informatics. Governments increasingly prefer proven Bio Preservation market companies that can deliver turnkey solutions and regulatory documentation.
Bio Preservation Market Emerging Challengers & Disruptive Start-Ups
Emerging Challengers & Disruptive Start-Ups
Develops next-generation vitrification-based preservation platforms designed to reduce ice crystal formation for sensitive cell and tissue samples.
Offers AI-driven freezer management software that predicts failures, optimizes energy use, and orchestrates inventory across multi-site biobanks.
Provides serum-free, chemically defined cryopreservation media tailored for CAR-T and iPSC workflows, emphasizing regulatory-ready formulations.
Specializes in sustainable, reusable cold-chain containers and route-optimization software for clinical trial and advanced therapy shipments.
Delivers low-cost IoT sensors and cloud dashboards enabling small labs and hospitals to monitor preservation equipment in real time.
Explores nanomaterial-enhanced cooling surfaces to achieve faster, more uniform freezing profiles for high-value biological samples.
Bio Preservation Market Future Outlook & Key Success Factors (2026-2032)
From 2025 to 2031, cumulative investments in metro expansions and station safety upgrades are projected to surpass significant amounts. The total market will scale from US$ 2.27 Billionin 2025 to US$ 3.38 Billion by 2031, reflecting a 6.90% CAGR. Winning Bio Preservation market companies will share several attributes. First, they will embed native IoT sensors, enabling predictive maintenance contracts that can double recurring revenue within five years. Second, modular design philosophies—interchangeable panels, plug-and-play controllers—will shorten installation windows and appeal to cost-sensitive public operators.
Localization strategies will also define competitive edges. Suppliers that establish regional assembly plants to meet content rules in India, Brazil, or the U.S. are likely to capture bonus points in tenders. Finally, sustainability credentials will move from optional to mandatory. Recyclable composite panels, energy-efficient brushless motors, and life-cycle carbon disclosures will become bid differentiators. In short, the coming decade rewards Bio Preservationmarket companies that marry digital intelligence with manufacturing agility and regulatory foresight.
Frequently Asked Questions
Find answers to common questions about this company report.